Granules India enters agreement to divest entire stake in JV Granules-Biocause Pharmaceutical
Granules India has entered into an agreement with Hubei Biocause Heilen Pharmaceutical Co., Joint Venture Partner for sale of 33,000,000 equity shares of 1 RMB each fully paid-up held by the Company in overseas JV company, Granules-Biocause Pharmaceutical Co. situated in China for a consideration of RMB 109 million. Conclusion of this transaction is subject to fulfilment of certain closing conditions as well as applicable regulatory approvals.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 14 2019 | 1:03 PM IST